Literature DB >> 16837921

FSGS-associated alpha-actinin-4 (K256E) impairs cytoskeletal dynamics in podocytes.

J-L R Michaud1, K M Chaisson, R J Parks, C R J Kennedy.   

Abstract

Mutations in the ACTN4 gene, encoding the actin crosslinking protein alpha-actinin-4, are associated with a familial form of focal segmental glomerulosclerosis (FSGS). Mice with podocyte-specific expression of K256E alpha-actinin-4 develop foot process effacement and glomerulosclerosis, highlighting the importance of the cytoskeleton in podocyte structure and function. K256E alpha-actinin-4 exhibits increased affinity for F-actin. However, the downstream effects of this aberrant binding on podocyte dynamics remain unclear. Wild-type and K256E alpha-actinin-4 were expressed in cultured podocytes via adenoviral infection to determine the effect of the mutation on alpha-actinin-4 subcellular localization and on cytoskeletal-dependent processes such as adhesion, spreading, migration, and formation of foot process-like peripheral projections. Wild-type alpha-actinin-4 was detected primarily in the Triton-soluble fraction of podocyte lysates and localized to membrane-associated cortical actin and focal adhesions, with some expression along stress fibers. Conversely, K256E alpha-actinin-4 was detected predominantly in the Triton-insoluble fraction, was excluded from cortical actin, and localized almost exclusively along stress fibers. Both wild-type and K256E alpha-actinin-4-expressing podocytes adhered equally to an extracellular matrix (collagen-I). However, podocytes expressing K256E alpha-actinin-4 showed a reduced ability to spread and migrate on collagen-I. Lastly, K256E alpha-actinin-4 expression reduced the mean number of actin-rich peripheral projections. Our data suggest that aberrant sequestering of K256E alpha-actinin-4 impairs podocyte spreading, motility, and reduces the number of peripheral projections. Such intrinsic cytoskeletal derangements may underlie initial podocyte damage and foot process effacement encountered in ACTN4-associated FSGS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16837921     DOI: 10.1038/sj.ki.5001665

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  30 in total

Review 1.  Educational paper: the podocytopathies.

Authors:  Anja K Büscher; Stefanie Weber
Journal:  Eur J Pediatr       Date:  2012-01-13       Impact factor: 3.183

2.  Proteinuria: is it all in the foot?

Authors:  Pierre Ronco
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

Review 3.  TRPC6 in glomerular health and disease: what we know and what we believe.

Authors:  Johannes S Schlöndorff; Martin R Pollak
Journal:  Semin Cell Dev Biol       Date:  2006-11-20       Impact factor: 7.727

Review 4.  Diabetes and Kidney Disease: Role of Oxidative Stress.

Authors:  Jay C Jha; Claudine Banal; Bryna S M Chow; Mark E Cooper; Karin Jandeleit-Dahm
Journal:  Antioxid Redox Signal       Date:  2016-04-01       Impact factor: 8.401

Review 5.  Hereditary Podocytopathies in Adults: The Next Generation.

Authors:  Olivia Boyer; Guillaume Dorval; Aude Servais
Journal:  Kidney Dis (Basel)       Date:  2017-05-31

6.  Alpha-actinin-4 and CLP36 protein deficiencies contribute to podocyte defects in multiple human glomerulopathies.

Authors:  Zhongmin Liu; Simone Monika Blattner; Yizeng Tu; Robert Tisherman; James H Wang; Maria Pia Rastaldi; Matthias Kretzler; Chuanyue Wu
Journal:  J Biol Chem       Date:  2011-06-16       Impact factor: 5.157

Review 7.  Genetic causes of proteinuria and nephrotic syndrome: impact on podocyte pathobiology.

Authors:  Oleh Akchurin; Kimberly J Reidy
Journal:  Pediatr Nephrol       Date:  2014-03-02       Impact factor: 3.714

8.  Shiga toxin promotes podocyte injury in experimental hemolytic uremic syndrome via activation of the alternative pathway of complement.

Authors:  Monica Locatelli; Simona Buelli; Anna Pezzotta; Daniela Corna; Luca Perico; Susanna Tomasoni; Daniela Rottoli; Paola Rizzo; Debora Conti; Joshua M Thurman; Giuseppe Remuzzi; Carlamaria Zoja; Marina Morigi
Journal:  J Am Soc Nephrol       Date:  2014-02-27       Impact factor: 10.121

9.  Crystal structure of the actin-binding domain of alpha-actinin-4 Lys255Glu mutant implicated in focal segmental glomerulosclerosis.

Authors:  Sung Haeng Lee; Astrid Weins; David B Hayes; Martin R Pollak; Roberto Dominguez
Journal:  J Mol Biol       Date:  2007-12-04       Impact factor: 5.469

10.  Relevance of the ACTN4 gene in African-Americans with non-diabetic end-stage renal disease.

Authors:  Meredith A Bostrom; Peter Perlegas; Lingyi Lu; Pamela J Hicks; Greg Hawkins; Maggie C Y Ng; Carl D Langefeld; Barry I Freedman; Donald W Bowden
Journal:  Am J Nephrol       Date:  2012-09-04       Impact factor: 3.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.